论文信息 - Randomised proof-of-concept phase II trial comparing targeted therapy based on tumour molecular profiling vs conventional therapy in patients with refractory cancer: results of the feasibility part of the SHIVA trial - 字舞流文

Randomised proof-of-concept phase II trial comparing targeted therapy based on tumour molecular profiling vs conventional therapy in patients with refractory cancer: results of the feasibility part of the SHIVA trial

P. Gestraud | O. Mariani | A. Vincent-Salomon | V. Servois | I. Bièche | X. Paoletti | M. Campone | N. Servant | V. Bernard | O. Trédan | M. Kamal | C. Reyes | D. Gentien | E. Rouleau | P. La Rosa | A. Gonçalves | G. Pierron | N. Isambert | C. Le Tourneau | J. Delord | C. Gavoille | C. Mauborgne | T. Rio Frio | C. Callens | E. Mitry | J. Wong | J. Roméjon | P. Huppé | F. Mulot | E. Henry | Q. Leroy | L. Escalup | C. le Tourneau